... at Oregon State University have developed a new “organocatalyst” that will play a major role in new drug development, greatly reducing costs while making the process more efficient, effective and ...
... —and human clinical trials. Inadequately designed rodent studies have led to missteps and delays in previous drug development programs.
In a commentary, Melinda Hollingshead, D.V.M., Ph.D., of the ...
... Research will announce its new intelligent pill technology “iPill”, targeted at assisting drug development and enabling new therapies for debilitating and life-threatening digestive tract disorders ...
... understanding and modelling the complex interactions of the human, leading to more effective and faster drug development. Europe is now at the forefront of this growing movement that brings together a ...
... , the complex nature of diseases for which new therapeutics are being developed has resulted in longer clinical development times, according to the Tufts Center for the Study of Drug Development.
Focusing HIV drug development on immune cells called macrophages instead of traditionally targeted T ... HIV disease — are an obvious target for HIV drug development because they die soon after infection, ...
... are likely to produce.
Professor Humphries added: "Our findings will be of great interest to scientists and pharmaceutical companies as they open up new avenues for drug development and testing."
... Cancer Institute summarizes a set of critical decision points in cancer biomarker and drug development. The points, which emerged from a workshop, include developing a clear understanding of the ...
... .”
“We are excited about the success of this work and the prospects it holds for future drug development,” said USAMRIID principal investigator S. Ashraf Ahmed, who initiated the structure-based ...
... the degradation of collagens. This effect is evidently different from that of Western antifibrogenic drugs and could allow for the development of effective antifibrogenic drugs from Chinese medicinal ...
... molecules and directing cells to grow, change shape and move.
Kinases have been the focus of drug development strategies for years, with some protein kinase-inhibiting compounds, such as Gleevec, ...
A drug developed to fight cancer is showing early promise as a treatment for pulmonary hypertension, researchers from the University of Chicago Medical Center report May 19 at the American Thoracic ...
... news and a major step forward in finding a drug to treat adenovirus infections in humans,” said William ... CMX001 is an oral pro-drug, or derivative, of cidofovir, a drug developed by Gilead Sciences, Inc ...
A drug developed to fight cancer is showing early promise as a treatment for pulmonary hypertension, researchers from the University of Chicago Medical Center report May 19 at the American Thoracic ...
... gene, those cells emit light.
Some cancer drugs, however, work by cutting off the blood ... BLI may be an effective and cheaper method to assess drug development and effectiveness,” said Dr. Ralph Mason ...
